Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/1998
06/02/1998US5760175 Peptide to detect several herpes virus infections
06/02/1998US5760072 Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
06/02/1998US5759994 Antithrombin peptide for cardiovascular disorders
06/02/1998US5759993 Modified sialyl Lewisx compounds
06/02/1998US5759992 Immunotherapeutic agent derived from bacteria and method for its manufacture
06/02/1998US5759841 Immunological composition of measles virus utilizing recombinant poxvirus
06/02/1998US5759818 N-terminal CTP extended pharmaceutical peptides and proteins
06/02/1998US5759814 Genetic engineering and dna for gene expression of glucosylated polypeptides in eukarotic host cells, oligonucleotide sequences, transcription and translational regulatory sequences and transformation
06/02/1998US5759813 Methods and compositions relating to useful antigens of moraxella catarrhalis
06/02/1998US5759808 Immunoglobulins devoid of light chains
06/02/1998US5759804 Culture product
06/02/1998US5759792 Antigenic regions of tumour-liberated particles (TLP) complexes and antibodies against the same
06/02/1998US5759789 Prostaglandin receptor EP2
06/02/1998US5759783 Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene
06/02/1998US5759770 Retrovirus from the HIV group and its use
06/02/1998US5759769 Diagnostic kits, vaccines; immobilized peptide having amino acid sequence epitope
06/02/1998US5759572 Liposome with oligosaccharide on surface
06/02/1998US5759554 Immunostimulatory bacterial cell wall traction
06/02/1998US5759553 Polypeptides
06/02/1998US5759552 Marek's disease virus recombinant poxvirus vaccine
06/02/1998US5759551 Luteinizing hormone releasing hormone peptides that prevent growth of the prostate gland
06/02/1998US5759546 Treatment of CD4 T-cell mediated conditions
06/02/1998US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses
06/02/1998US5759535 Immunotherapeutic strategies for the treatment of cancer
06/02/1998US5759514 Composition for delivery of toxic radioisotopes to the cell nucleus and use
05/1998
05/28/1998WO1998022605A1 Improved methods for transducing cells
05/28/1998WO1998022589A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998WO1998022580A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
05/28/1998WO1998022579A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition
05/28/1998WO1998022575A2 Nucleotide sequence of escherichia coli pathogenicity islands
05/28/1998WO1998022506A1 Human kdel receptor
05/28/1998WO1998022149A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33
05/28/1998WO1998022145A1 Immunization of infants
05/28/1998WO1998022138A1 Method for treating symptoms of diabetes
05/28/1998WO1998022137A1 SUPPRESSION OF TNF α AND IL-12 IN THERAPY
05/28/1998WO1998022136A2 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022100A2 New use for 1,3-propanediol derivatives
05/28/1998WO1998021951A1 Methods and compositions for inducing oral tolerance in mammals
05/28/1998WO1998001550A3 Vaccine against gastro-intestinal nematodes
05/28/1998DE19648687A1 Composition containing immunomodulatory peptide or protein and adjuvant
05/28/1998CA2633660A1 Method for treating symptoms of diabetes
05/28/1998CA2275438A1 Improved methods for transducing cells
05/28/1998CA2272824A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition
05/28/1998CA2272093A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33
05/28/1998CA2272047A1 Nucleotide sequence of escherichia coli pathogenicity islands
05/28/1998CA2271783A1 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998CA2270407A1 Human kdel receptor
05/28/1998CA2243643A1 Methods and compositions for inducing oral tolerance in mammals
05/27/1998EP0844307A1 Candida albicans protein caYAE1
05/27/1998EP0844305A2 hRAD54
05/27/1998EP0843818A1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
05/27/1998EP0843583A1 Golf club receptacle
05/27/1998EP0843557A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
05/27/1998EP0596032B1 Induction of cytotoxic t-lymphocyte responses
05/27/1998CN1183117A Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies
05/27/1998CN1183046A Composition of tyrosine and polymerised allergen
05/27/1998CN1183043A Preparation and use of sulfated oligosaccharides
05/27/1998CA2216625A1 Novel compounds
05/26/1998US5756687 Isolation of components of interest from milk
05/26/1998US5756682 Antibodies that bind specifically to polypeptide
05/26/1998US5756674 Fusion proteins
05/26/1998US5756666 Peptides capable of inducing immune response to HIV
05/26/1998US5756664 Genetic engineering of proteins with nucleotide sequences for bones
05/26/1998US5756662 Detecting trypanosoma infection by contacting biological sample with specified polypeptide, detecting presence of antibodies binding thereto
05/26/1998US5756448 Constitute activator of retinoid (CAR) receptor polypeptides
05/26/1998US5756353 Introducing dna into cell of proximal or distal airways of a mammal by administering aerosol lipid-dna complex
05/26/1998US5756349 Culture of cells and radioimmunoassay
05/26/1998US5756343 Cell stress transcriptional factors
05/26/1998US5756342 Monoclonal antibody or antigen binding fragment thereof, capable of blocking suppression of gamma-interferon
05/26/1998US5756341 Culturing monkey kidey cells in serum-free medium, infecting with influenza virus having modified cleavage site, incubating to produce antigen, removing portion, contacting with protease which activates virus, adding inhibitor, returning to culture
05/26/1998US5756330 Glycyl tRNA synthetase polynucleotides of streptococcus
05/26/1998US5756329 DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus
05/26/1998US5756323 Genetic engineering
05/26/1998US5756312 Dna molecule encoding polypeptide comprising two heterogeneous amino acid sequences from same variable domain of hepatitis c virus isolates
05/26/1998US5756310 Culture product
05/26/1998US5756284 Self-assembling recombinant papillomavirus capsid proteins
05/26/1998US5756281 Stealth virus detection in the chronic fatigue syndrome
05/26/1998US5756264 Expression vector systems and method of use
05/26/1998US5756105 Vaccine for prevention of hemophilus influenzae infection
05/26/1998US5756104 Liposome-containing intranasal vaccine formulation
05/26/1998US5756103 Alvac canarypox virus recombinants comprising heterlogous inserts
05/26/1998US5756102 Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
05/26/1998US5756101 Malaria recombinant poxvirus
05/26/1998US5756097 Immunotherapeutic treatment of cancer
05/26/1998US5756095 Immunoassays for detection of adhesion molecules
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/25/1998CA2216622A1 Novel compounds
05/25/1998CA2215929A1 Novel lep
05/22/1998WO1998021364A2 Method and apparatus for preparing sample cartridges for a particle acceleration device
05/22/1998WO1998021359A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998WO1998021354A1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
05/22/1998WO1998021344A1 Chimeric ltb vaccines
05/22/1998WO1998021343A1 Genes encoding telomerase proteins
05/22/1998WO1998021338A1 Synthesis and purification of hepatitis c virus-like particles
05/22/1998WO1998021337A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
05/22/1998WO1998021331A1 Human breast tumor-specific proteins
05/22/1998WO1998021327A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/22/1998WO1998021324A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof
05/22/1998WO1998021243A1 Method and novel compounds for use therein